SOLICITATION NOTICE
65 -- Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells
- Notice Date
- 2/2/2022 5:51:36 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95022Q00081
- Response Due
- 2/8/2022 6:00:00 AM
- Archive Date
- 02/10/2022
- Point of Contact
- Kimberly Espinosa, Phone: 3018273546
- E-Mail Address
-
kimberly.espinosa@nih.gov
(kimberly.espinosa@nih.gov)
- Description
- THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).� The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Fujifilm Cellular Dynamics, Inc., 465 Science Drive, Madison, Wisconsin 53711-1074 for induced pluripotent stem (iPS) cell-derived differentiated cells. NCATS has been using this vendor�s neuronal cells and endothelial cells for the biofabrication of 3D tissue models and it is critical to continue using this vendor�s cells to keep uniform data going forward and avoid variables that could skew results. The Stem Cell Translations Laboratory (SCTL) within the Division of PreClinical Innovation (DPI) of the National Center for Advancing Translational Sciences (NCATS) seeks to purchase Induced pluripotent stem (iPS) cell-derived differentiated cells. See attachments for complete requirement details.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/b37a34c221f74f19b311daeb6749fc1d/view)
- Record
- SN06231610-F 20220204/220202230102 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |